STERIS Comprehensive Income 2010-2024 | STE
STERIS comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- STERIS comprehensive income for the quarter ending September 30, 2024 was $-0.166B, a 57.12% decline year-over-year.
- STERIS comprehensive income for 2024 was $-0.329B, a 2.48% increase from 2023.
- STERIS comprehensive income for 2023 was $-0.321B, a 52.86% increase from 2022.
- STERIS comprehensive income for 2022 was $-0.21B, a 242.58% increase from 2021.
| STERIS Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-329 |
| 2023 | $-321 |
| 2022 | $-210 |
| 2021 | $-61 |
| 2020 | $-235 |
| 2019 | $-160 |
| 2018 | $12 |
| 2017 | $-241 |
| 2016 | $-68 |
| 2015 | $-67 |
| 2014 | $4 |
| 2013 | $-4 |
| 2012 | $14 |
| 2011 | $35 |
| 2010 | $13 |
| 2009 | $-16 |
| STERIS Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-166 |
| 2024-06-30 | $-323 |
| 2024-03-31 | $-329 |
| 2023-12-31 | $-253 |
| 2023-09-30 | $-387 |
| 2023-06-30 | $-311 |
| 2023-03-31 | $-321 |
| 2022-12-31 | $-364 |
| 2022-09-30 | $-598 |
| 2022-06-30 | $-388 |
| 2022-03-31 | $-210 |
| 2021-12-31 | $-137 |
| 2021-09-30 | $-106 |
| 2021-06-30 | $-37 |
| 2021-03-31 | $-61 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-131 |
| 2020-06-30 | $-208 |
| 2020-03-31 | $-235 |
| 2019-12-31 | $-149 |
| 2019-09-30 | $-226 |
| 2019-06-30 | $-157 |
| 2019-03-31 | $-160 |
| 2018-12-31 | $-167 |
| 2018-09-30 | $-127 |
| 2018-06-30 | $-121 |
| 2018-03-31 | $12 |
| 2017-12-31 | $-55 |
| 2017-09-30 | $-80 |
| 2017-06-30 | $-148 |
| 2017-03-31 | $-241 |
| 2016-12-31 | $-275 |
| 2016-09-30 | $-94 |
| 2016-06-30 | $-86 |
| 2016-03-31 | $-68 |
| 2015-12-31 | $-74 |
| 2015-09-30 | $-59 |
| 2015-06-30 | $-54 |
| 2015-03-31 | $-67 |
| 2014-12-31 | $-32 |
| 2014-09-30 | $-13 |
| 2014-06-30 | $9 |
| 2014-03-31 | $4 |
| 2013-12-31 | $4 |
| 2013-09-30 | $3 |
| 2013-06-30 | $-9 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $10 |
| 2012-09-30 | $8 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $14 |
| 2011-12-31 | $10 |
| 2011-09-30 | $20 |
| 2011-06-30 | $44 |
| 2011-03-31 | $35 |
| 2010-12-31 | $21 |
| 2010-09-30 | $21 |
| 2010-06-30 | $-0 |
| 2010-03-31 | $13 |
| 2009-12-31 | $18 |
| 2009-09-30 | $16 |
| 2009-06-30 | $8 |
| 2009-03-31 | $-16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.298B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.408B | 24.08 |
| Intuitive Surgical (ISRG) | United States | $196.120B | 102.54 |
| Alcon (ALC) | Switzerland | $42.207B | 28.24 |
| Edwards Lifesciences (EW) | United States | $41.510B | 26.36 |
| IQVIA Holdings (IQV) | United States | $35.864B | 19.76 |
| IDEXX Laboratories (IDXX) | United States | $34.273B | 40.36 |
| DexCom (DXCM) | United States | $29.084B | 43.80 |
| Waters (WAT) | United States | $21.880B | 32.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.458B | 0.00 |
| Hologic (HOLX) | United States | $18.284B | 19.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 13.24 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.562B | 29.28 |
| Penumbra (PEN) | United States | $9.230B | 90.41 |
| Masimo (MASI) | United States | $9.055B | 43.81 |
| Teleflex (TFX) | United States | $8.854B | 14.12 |
| Glaukos (GKOS) | United States | $7.765B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.929B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| Veracyte (VCYT) | United States | $3.018B | 90.56 |
| Inari Medical (NARI) | United States | $2.913B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.807B | 16.21 |
| TransMedics (TMDX) | United States | $2.663B | 84.40 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 18.44 |
| Elekta AB (EKTAY) | Sweden | $2.125B | 17.31 |
| Tandem Diabetes Care (TNDM) | United States | $2.019B | 0.00 |
| RxSight (RXST) | United States | $1.816B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.775B | 9.27 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Artivion (AORT) | United States | $1.175B | 77.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.828B | 14.08 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.714B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.548B | 12.91 |
| SiBone (SIBN) | United States | $0.515B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 32.40 |
| Tactile Systems Technology (TCMD) | United States | $0.383B | 20.70 |
| CVRx (CVRX) | United States | $0.358B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.315B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| NeuroPace (NPCE) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.150B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.67 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |